DKK1 and steatosis: On the other hand, elevated DKK1 expression activates the JNK signaling pathway, which further inhibits AKT-FOXO1 phosphorylation cascades, promoting insulin resistance and glucose metabolism disturbances, thereby accelerating excessive lipid accumulation and steatosis (Fig 7).